Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 21 | 27 | 50 | 36 | 26 | 153 |
Hiv | D006678 | — | O98.7 | 7 | 5 | 11 | 12 | 14 | 47 |
Healthy volunteers/patients | — | — | — | 9 | — | — | 1 | — | 10 |
Hiv-1 | D015497 | — | — | 2 | 3 | 2 | 2 | 2 | 10 |
Infections | D007239 | EFO_0000544 | — | — | 2 | 3 | 2 | — | 7 |
Hepatitis c | D006526 | — | B19.2 | 2 | 2 | 1 | 2 | — | 6 |
Drug interactions | D004347 | — | — | — | — | — | 1 | 2 | 3 |
Dyslipidemias | D050171 | HP_0003119 | — | — | — | — | 2 | — | 2 |
Lipodystrophy | D008060 | HP_0009125 | E88.1 | — | — | — | 1 | 1 | 2 |
Metabolic bone diseases | D001851 | HP_0000938 | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | — | 3 | 6 | — | 2 | 9 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | 1 | 2 | 2 | — | 1 | 5 |
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 1 | 1 | — | 3 | 4 |
Covid-19 | D000086382 | — | U07.1 | — | 2 | 1 | — | — | 2 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 2 | 1 | — | — | 2 |
Hyperlipidemias | D006949 | HP_0003077 | E78.5 | — | — | 2 | — | — | 2 |
Coronavirus infections | D018352 | EFO_0007224 | B34.2 | — | 1 | 1 | — | — | 1 |
Sars-cov-2 | D000086402 | — | — | — | 1 | 1 | — | — | 1 |
Hepatitis b | D006509 | — | — | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hematologic neoplasms | D019337 | — | — | 1 | — | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Toxoplasmosis | D014123 | EFO_0007517 | B58 | 1 | — | — | — | — | 1 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | — | — | — | — | 1 |
Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Nephrolithiasis | D053040 | — | N20.0 | — | — | — | — | 1 | 1 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | — | — | — | — | 1 | 1 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | — | — | 1 | 1 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 1 | 1 |
Female genital diseases | D005831 | EFO_0009549 | N85 | — | — | — | — | 1 | 1 |
Sepsis | D018805 | HP_0100806 | A41.9 | — | — | — | — | 1 | 1 |
Multiple organ failure | D009102 | EFO_1001373 | — | — | — | — | — | 1 | 1 |
Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 1 | 1 |
Endotoxemia | D019446 | — | — | — | — | — | — | 1 | 1 |